GM Rice Researcher Barred from Human Studies

The lead investigator on a controversial study announces her retirement as Tufts releases a report citing ethics violations in genetically modified food research.

Written byErin Weeks
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, IRRI IMAGESOne year ago, the publication of a study on vitamin A uptake in Chinese children fed golden rice sparked a fierce controversy that resulted in several scientists and government officials affiliated with the study losing their jobs. This week (September 17), Tufts University released the findings from its investigation into the research and the actions of the lead investigator, the school’s own Guangwan Tang.

The scrutiny has centered on whether the 24 children who participated in the research and their families were given adequate explanation of the two-year study. Golden rice is a genetically modified variety that contains beta-carotene, designed to combat vitamin A deficiencies in developing countries. The study consent forms made no mention of genetic modification (GM), but instead referred to the golden rice as a “new rice”, likely because US federal guidelines require such forms be written in easy-to-understand language, and GM food remains—as in the U.S.—a charged issue in China.

Tufts concluded that “while the study data were validated and no health or safety concerns were identified, the research itself was found not to have been conducted in full compliance with IRB [institutional review board] ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies